Analyst
Sales
Board Member
Xeris Biopharma Holdings, Inc. (XERS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2026-07-01–present
2024-08-01–present
Sales
Analyst
Source not stated
Recorded roles and earnings-call appearances connecting this person to public companies.
COO, CEO, Chairman, Board Member
2024-08-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer | $742,334 | $5,042,584 |
| 2024 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer | $629,193 | $3,827,109 |
| 2023 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer | $571,411 | $1,848,153 |
| 2022 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer | $549,433 | $1,530,218 |
| 2021 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $527,500 | $1,728,640 |
| 2020 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | $473,658 | $1,436,428 |
Earnings-call appearances and filed executive appointments or departures, newest first.
